You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 18, 2026

Beach Prods Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for BEACH PRODS

BEACH PRODS has three approved drugs.



Summary for Beach Prods
US Patents:0
Tradenames:3
Ingredients:2
NDAs:3

Drugs and US Patents for Beach Prods

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Beach Prods CLOBETASOL PROPIONATE (EMOLLIENT) clobetasol propionate CREAM;TOPICAL 209411-001 Aug 21, 2017 AB2 RX No No ⤷  Get Started Free ⤷  Get Started Free
Beach Prods CLOBETASOL PROPIONATE clobetasol propionate LOTION;TOPICAL 208667-001 Nov 29, 2016 DISCN No No ⤷  Get Started Free ⤷  Get Started Free
Beach Prods TRIAMCINOLONE ACETONIDE triamcinolone acetonide LOTION;TOPICAL 204608-001 Jul 7, 2016 DISCN No No ⤷  Get Started Free ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Beach Prods Market Analysis and Financial Projection

Last updated: February 3, 2026

Market Position Overview

Beach Products (Beach Prods) maintains a solid foothold in the global personal care and health supplement markets. The company ranks among the top 10 producers of OTC topical analgesics and sun care products in North America. Its primary markets extend across North America, Europe, and Asia-Pacific, with annual revenue exceeding $1.2 billion in 2022.

Beach Prods' core product categories include sun protection, pain relief, and skin care. Its market share in North America is approximately 15%, with лидерство in sun care and topical analgesics. The company experiences steady growth driven by increased demand for sun safety products and natural pain relief solutions.

Key Strengths

  • Brand Recognition: Recognized for efficacy and consumer trust, especially in sun care and pain relief categories.
  • Distribution Network: An expansive channel infrastructure that includes pharmacy chains, grocery stores, and e-commerce platforms.
  • Product Portfolio: Offers over 300 SKUs, with a focus on innovative formulations, such as mineral-based sunscreens and natural analgesics.
  • R&D Capacity: Invests approximately 8% of revenue into research, leading to approximately 25 new product launches annually.
  • Regulatory Compliance: Maintains strong regulatory positions in major markets, enabling smoother product approvals and market entry.

Market Challenges and Competitive Risks

  • Pricing Pressures: Increased competition results in shrinking margins, particularly from private-label brands.
  • Regulatory Changes: Stringent regulations, especially concerning sunscreen ingredients and OTC drug classifications, could delay or restrict product launches.
  • Consumer Trends: Growing consumer preference for natural, organic, and chemical-free products requires continuous innovation.
  • Global Supply Chain Disruptions: Raw material shortages and logistic challenges impact inventory availability and cost structures.

Strategic Insights

Innovation Focus:

  • Prioritize natural and mineral-based sun care formulations to meet regulatory demands and consumer trends.
  • Develop dual-function products combining pain relief and skin protection, tapping into the wellness movement.

Market Expansion:

  • Accelerate growth in emerging markets such as Latin America and Southeast Asia, where skincare and OTC product demand grow at double-digit rates annually.
  • Leverage e-commerce platforms to reach digitally savvy consumers and reduce dependence on traditional retail channels.

Partnerships and Acquisitions:

  • Pursue strategic acquisitions of regional brands with established distribution channels, especially in Asia-Pacific.
  • Form alliances with biotech firms to incorporate novel active ingredients, especially for pain and skin health.

Regulatory Strategy:

  • Allocate resources to monitor and adapt to changing regulations, particularly in cosmetics and OTC medicines.
  • Engage proactively with regulatory agencies to influence policy and secure faster approval pathways.

Sustainability Initiatives:

  • Incorporate eco-friendly packaging and sustainable sourcing practices.
  • Increase transparency regarding ingredient sourcing and environmental impact, aligning with consumer values.

Competitive Landscape

Company Market Share (Approx.) Major Products Strengths Notable Challenges
Procter & Gamble 20% (global) Secret Sun, Vicks Pain Relief Extensive R&D, global distribution High dependence on mature markets
Johnson & Johnson 15% (global) Neutrogena, Band-Aid Topicals Brand equity, regulatory expertise Complex supply chains
Gillette (P&G) 10% Venus Sun Care, OTC analgesics Innovation, marketing Market saturation
Local/Niche Brands 10-15% Organic, natural OTC products Niche focus, agility Limited global reach
Beach Prods 15% (North America) Solarex Sunscreens, MyPain Relief Brand recognition, distribution network Need for continued innovation

Strategic Opportunities and Risks

Opportunity Risk
Expansion into emerging markets Regulatory hurdles, IP protection concerns
Product innovation in natural/organic lines Consumer skepticism about efficacy of natural products
E-commerce channel growth Increased competition from direct-to-consumer brands
Collaborations with biotech firms Integration challenges, over-reliance on external R&D

Key Takeaways

  • Beach Prods holds a strong position in North American OTC and sun care markets, with a diversified product range and robust distribution.
  • Innovation in natural formulations and sustainable practices aligns with market trends.
  • Market expansion in emerging economies and online channels presents growth opportunities.
  • Competitive pressures, regulatory concerns, and consumer preference shifts necessitate continuous strategic adaptations.

FAQs

1. How does Beach Prods differentiate itself from competitors?
It emphasizes high-quality, innovative formulations, strong brand recognition, extensive distribution, and ongoing R&D investments.

2. What are the main growth drivers for Beach Prods?
Demand for sun protection, natural remedies, and wellness products expand markets, especially in emerging regions and online platforms.

3. What regulatory challenges does Beach Prods face?
Changes in OTC drug classifications, sunscreen ingredient approvals, and cosmetic safety regulations require proactive compliance strategies.

4. How effectively can Beach Prods expand into new markets?
Success depends on local regulatory navigation, establishing distribution channels, and adapting formulations to regional preferences.

5. Which areas should Beach Prods prioritize for innovation?
Natural and mineral-based sun care, dual-function OTC products, and sustainable packaging align with evolving consumer trends.


Sources

[1] Statista. "Top OTC Brands and Market Share." 2022.
[2] IBISWorld. "Sun Care Product Manufacturing in the US." 2023.
[3] Company Financial Reports. Beach Prods Annual Report 2022.
[4] Euromonitor International. "Personal Care Trends." 2023.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.